Trial Profile
A Relative Bioavailability Trial to Investigate the Pharmacokinetics of Different Amounts of Tablets of Two Immediate Release Fixed Dose Combinations of Hydrocodone Bitartrate 5 mg/Acetaminophen 325 mg (a New Abuse Deterrent Tablet and a Marketed Tablet) Under Fasted Conditions in Healthy Male and Female Adult Subjects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Acute pain; Postoperative pain
- Focus Pharmacokinetics
- Sponsors Grunenthal
- 19 Jul 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 05 May 2017 New trial record